GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis Please like and subscribe if you enjoyed this video :-) Abstract The treatment landscape for managing weight in non-diabetic patients has changed dramatically with the introduction of
Tag: Semaglutide
Semaglutide Use Shows Bonus Benefit Of Osteoarthritis Risk Reduction
Semaglutide Use Shows Bonus Benefit Of Osteoarthritis Risk Reduction Overview Osteoarthritis (OA) is a widespread degenerative joint condition. While the influence of obesity on OA is well-established, the effect of semaglutide on OA remains less understood. The objective was to evaluate the effect of semaglutide on the risk of OA among patients with
